Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing.

Main|Search|PHGKB




Last Posted: Dec 17, 2017

---

• Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing.  
  Kim Annette S et al. JAMA oncology 2017 Dec
• Precision Medicine and Testing for Tumor Biomarkers—Are All Tests Born Equal?  
  DF Hayes, JAMA Oncology, Dec 14, 2017
• Using the Seven Bridges Cancer Genomics Cloud to Access and Analyze Petabytes of Cancer Data.  
  Malhotra Raunaq et al. Current protocols in bioinformatics 2017 Dec 6011.16.1-11.16.32
• ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research. 
  Madhavan Subha et al. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2018 23247-258
• A Comprehensive Cancer Gene Test Gets the Go-Ahead  
  K Sheikh, Genome Magazine, Dec 4, 2017
• FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers  
  CMS, NOv 30, 2017
• Foundation's cancer gene test gets U.S. FDA and Medicare nod  
  Reuter;s Health, Nov 30, 2017
• LinkedOmics: analyzing multi-omics data within and across 32 cancer types.  
  Vasaikar Suhas V et al. Nucleic acids research 2017 Nov
• Genomic studies track early hints of cancer  
  H Ledford, Nature News, Oct 27, 2017
• Study Uses Open Data to Analyze “Normal” Tissue Near Tumors  
• 1 to 10 mutations are needed to drive cancer, scientists find  
  Sanger Institute, Oct 19, 2017
• A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.  
  Nagarajan Rakesh et al. Archives of pathology & laboratory medicine 2017 Oct
• Tumor DNA Sequencing in Cancer Treatment  
• OncoKB: A Precision Oncology Knowledge Base.  
  Chakravarty Debyani et al. JCO precision oncology 2017 Jul 2017
• Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing  
  D Mandelker et al, JAMA, September 5, 2017
• The Potential and Challenges of Expanded Germline Testing in Clinical Oncology  
  EM Van Allen, JAMA, September 5, 2017

more